News
Pharnext: Findings on Symptom Burden of Charcot-Marie-Tooth Disease Type 1A From ‘Real-World’ Digital Lifestyle Study, CMT&Me, to be Presented at the American Association of Neuromuscular & Electrodia
Verimatrix Threat Defense Technologies Deployed by Saudi Arabia’s Largest Online Shopping Service
Regulatory News:
Verimatrix, (Euronext Paris: VMX), the leader in powering the modern connected world with people-centered security, today announced that Jarir, Saudi Arabia’s largest ecommerce
Sensorion Announces First Patient Enrolled in Proof-of-Concept Clinical Trial of SENS-401 for Residual Hearing Preservation During Cochlear Implantation
Regulatory News:
Sensorion (FR0012596468 – ALSEN), a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within
Pharnext: Findings From ‘Real-World’ Digital Lifestyle Study, CMT&Me, on Symptom Burden of Charcot-Marie-Tooth Disease Type 1A Published in the Journal of Clinical Neuromuscular Disease
MYHOTELMATCH: PERFORMANCE AND INITIAL FIGURES 2022
Sensorion Receives Positive Opinion for Orphan Drug Designation for OTOF-GT for the Treatment of Otoferlin Gene-Mediated Hearing Loss From the European Medicine Agency
Regulatory News:
Sensorion (FR0012596468 – ALSEN) (Paris:ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and
Nanobiotix Announces Agreement in Principle to Restructure Existing Loan Agreement With European Investment Bank, Extending Operating Runway Into Q1 2024
Regulatory News:
NANOBIOTIX (Euronext: NANO –– NASDAQ: NBTX – the ‘‘Company’’), a late-clinical stage biotechnology company pioneering physics-based approaches to expand treatment possibilities
Transgene Confirms the Potential of the Intravenous Route of its Invir.IO™ Oncolytic Viruses against Solid Tumors with TG6002 Phase I Data Presented at ESMO Congress 2022
Regulatory News:
Transgene (Euronext Paris: TNG) (Paris:TNG), a biotech company that designs and develops virus-based immunotherapeutics against cancer, today announces positive confirmatory data
Pharnext Announces First Patient Enrolled in Open Label Extension of the Pivotal Phase III Study of PXT3003 for the Treatment of Charcot-Marie-Tooth Disease Type 1A, the PREMIER Trial
NexPlayer bietet leistungsstarke Kombination aus Videoqualität und Schutz durch Integration von Verimatrix Streamkeeper und Watermarking
Pflichtmitteilung:
Verimatrix, (Euronext Paris: VMX) (Paris:VMX), der führende Anbieter von Sicherheitslösungen für die moderne vernetzte Welt, gab heute bekannt, dass NexPlayer mit Sitz in
NexPlayer To Offer Powerful Combination of Video Quality and Protection through Integration with Verimatrix Streamkeeper and Watermarking
Regulatory News:
Verimatrix, (Euronext Paris: VMX) (Paris:VMX), the leader in powering the modern connected world with people-centered security, today announced that Madrid-based NexPlayer has
Fastway setzt Verimatrix Content-Sicherheitstechnologie in neuen Google Android Set-Top-Boxen ein
Verimatrix, (Euronext Paris: VMX), der Marktführer, wenn es um die Ausstattung der modernen vernetzten Welt mit Sicherheitsfunktionen geht, die den Menschen in den Mittelpunkt stellen, kündigt
Nanobiotix: Voting Rights and Shares Capital of the Company
Regulatory News:
Nanobiotix (Paris:NANO) (NASDAQ:NBTX):
Market: Euronext Paris / Nasdaq
Euronext Compartment: B
ISIN code: FR0011341205
Nasdaq: NBTX
Bloomberg: NANO:FP
Reuters: NANO.PA
Website
Teleperformance Certifies Record 64 Countries as Great Place to Work® Locations
Regulatory News:
Teleperformance (Paris:TEP), the global leader in outsourced customer and citizen experience management and related digital services, announced that its operations in 64
Fastway To Deploy Verimatrix Content Security Technology within New Google Android Set-Top Boxes
Regulatory News:
Verimatrix, (Euronext Paris: VMX), the leader in powering the modern connected world with people-centered security, today announced that Fastway Transmissions Private Limited
RUBIS: Availability of the 2022 half-year financial report
GEVELOT S.A.: Weekly report of share buyback September 8, 2022
RUBIS: H1 2022 results: Strong earnings growth: +20% and solid balance sheet
Successful Launch of New-generation EUTELSAT KONNECT VHTS Satellite
Regulatory News:
Eutelsat Communications (Euronext Paris: ETL) today announced that EUTELSAT KONNECT VHTS satellite was successfully launched into Geostationary Transfer Orbit by Arianespace
Sensorion to participate in the Inner Ear Biology Workshop in September 2022
Regulatory News:
Sensorion (FR0012596468 – ALSEN) (Paris:ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and
NANOBIOTIX and LianBio Announce First Patient Enrolled in Asia in Phase 3 NANORAY-312 Trial Evaluating NBTXR3 for the Treatment of Head and Neck Cancer
Regulatory News:
NANOBIOTIX (Euronext: NANO – Nasdaq: NBTX), a late-stage clinical biotechnology company pioneering physics-based approaches to expand treatment possibilities for patients with
Rémy Cointreau: Implementation of a Share Buyback Program
Regulatory News:
In accordance with resolutions 18 and 19 approved by the Shareholders’ Meeting on July 21, 20221, the Board of Directors of Rémy Cointreau (Paris:RCO) decided to authorize the
Positive Readouts for Transgene’s Clinical Stage Candidates Generated by its Two Innovative Platforms, with Further Clinical Data Expected in the Second Half of 2022
Regulatory News:
Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, today publishes its financial results for
Thanks to a new social impact investment, REALITES is now offsetting its entire carbon footprint